6. IHW: The outcome
Creating a system for
delivery of Innovation
Reducing Variation and
Strengthening Compliance
Incentives and Investment Procurement
Metrics and Information Developing our people
Leadership for Innovation High Impact Innovations
7. The AHSN Configuration
North West Coast North East and North Cumbria
Greater Manchester
Kent Surrey and Sussex
Yorkshire and Humber
East Midlands
Eastern
UCL Partners
Imperial College Health Partners
Oxford
Wessex
South LondonSouth West Peninsula
West of England
West Midlands
8. Key Objectives
• Develop the delivery capability for Innovation Health Wealth
• Using evidence and data, help NHS Commissioners and Providers understand and focus on
meeting the needs of patients and local populations more effectively and efficiently.
• Build a culture of partnership, collaboration and clinical leadership to deliver sustainable
change.
• Speed up translation of innovation into practice at pace and scale to improve clinical
outcomes, patient experience and cost effectiveness.
• Create wealth for the country by reducing the cost of engagement for business with the NHS
through simplified single point of access for.
• Forge new international partnerships.
9. Yorkshire and Humber AHSN
Industry Investment Industry Engagement
Identifying and
Adopting Innovation
Generating Growth
from Overseas
Markets
New Sources of
Inward Investment
Investment to
Accelerate Innovation
Account
Management
Bringing the NIHR
Arena together
Industry Access Portal
Open Innovation
Innovation Scouts
Test Beds
Innovation
Accelerator
Inward Investment
Exporting UK
Healthcare Expertise
10. Case Studies
New innovative diagnostic device adopted by AHSN
• AHSN support enabled:
• Validated cost consequence models
Outcomes:
• Engaged with CCGs to start crucial audit studies
• Engaged with key hospital clinics
• Networked across North of England AHSNs
• Future International work
• Focussed business cases
• Networks of key clinicians, GPs and support
agencies
Before I start, It might be useful for me to talk a little about the origin of AHSNs
In 2011, the NHS was at a turning point. We’d had a new coalition in place and beginning to bed down their ideastion
The Population was growing and living longer with more complex, resource draining conditions.
And all this, coupled with the economic challenges painted a very difficult future
So, these men here……..Sir David Nicholson and Sir Ian Currethers
Commissioned and delivered the Innovation Health and Wealth Review
This review was designed to support primarily the adoption and spread of innovation across the NHS and tounderstand why the NHS had been historically poor.
It identified 6 key barriers to the diffusion of innovation
Having identified the issues, IHW set out 8 key areas of focus.
The one highlighted in Orange is what gave rise to the AHSNs….it suggested building on the success of Academic Health Science Centres and creating a network of Academic Health Science Networks
So, we now have 15 AHSNs across the country of which the Yorkshire and the Humber is one.
We are all different geographical sizes, with different budgets, different operating structures and slightly different objectives
As mentioned before, we were established as a vehicle to deliver the findings of Innovation Health and Wealth
We are designed to provide systems leadership, bringing togeher the skills and expertise of multiple discplines across the health and care sector to promote improvement and efficient working across the system.
For 2015 / 16 the AHSN Commercial Team has 4 core areas of focus
New sources of inward investment – working collaboratively to seek out UK funding opportunities to bring into the region – working closely regional partners and LEPS to understand opportunities an cease them collaboratively
Prroof of concept funding and Commercial partnerships